What type of study is this?

This is a Cohort Study study (also classified as: Experimental Study).

October 3, 2025Current Neuropharmacology

Ginsenoside Rg2 Ameliorates Alzheimer's Disease by Alleviating Neuroinflammation in APP/PS1 Mice

View Full Paper

Ask AI

Bookmark

Authors

DYDilida Yeerkenbieke YGYue GuanInner Mongolia University for Nationalities JCJing Cui

Discussion

Member takes

Implication

This research demonstrates ginsenoside rg2's effects on cognitive function in APP/PS1 mice, suggesting neuroinflammation is a target for Alzheimer's disease therapy.

Key Points

Ginsenoside rg2 improves cognitive function and mitigates alzheimer's disease pathology, demonstrating its potential as a therapeutic intervention.
In APP/PS1 mice, cognitive assessments revealed that ginsenoside rg2 enhanced learning and memory, correlated with reduced neuroinflammation.
The study employed behavioral assessments, brain tissue analyses, and gut microbiome comparisons to explore ginsenoside rg2's mechanisms of action.
These findings support the neuroprotective role of ginsenoside rg2, emphasizing its effectiveness in managing alzheimer's disease through anti-neuroinflammatory actions.

Cite This Study

Yeerkenbieke et al. (2025) studied this question.

synapsesocial.com/papers/68e040eda99c246f578b33d0 https://doi.org/10.2174/011570159x395496250911104139

View Full Paper

Ask AI

Bookmark

Implication

This research demonstrates ginsenoside rg2's effects on cognitive function in APP/PS1 mice, suggesting neuroinflammation is a target for Alzheimer's disease therapy.

Ginsenoside Rg2 Ameliorates Alzheimer's Disease by Alleviating Neuroinflammation in APP/PS1 Mice

Discussion

Member takes

Implication

Key Points

Cite This Study

Ginsenoside Rg2 Ameliorates Alzheimer's Disease by Alleviating Neuroinflammation in APP/PS1 Mice

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider